Paper376307
Sodium valproate, serum level and clinical effect in epilepsy: a controlled study.
Gram L and 4 others. Epilepsia, 1979. Cited by 136 papers, by iCite.
Cite this record
ConductScience Library. Sodium valproate, serum level and clinical effect in epilepsy: a controlled study. Papers, record 376307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/376307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epilepsy | Major topic |
| Valproic Acid | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Carbamazepine | |
| Clinical Trials as Topic | |
| Dimethadione | |
| Dose-Response Relationship, Drug | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Phenobarbital | |
| Phenytoin |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40072331 | Evaluation of antiseizure medication concentration ranges in blood samples using an automated big data approach. | Epilepsia | 2025 | https://conductscience.org/library/papers/40072331 | PubMed |
| 39539630 | The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39539630 | PubMed |
| 34887756 | Switching Between LC-ESI-MS/MS and EMIT Methods for Routine TDM of Valproic Acid in Pediatric Patients With Epilepsy: What Clinicians and Researchers Need to Know. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34887756 | PubMed |
| 29955492 | Valproate serum concentrations in patients with hypoalbuminemia and medical complications. | Ment Health Clin | 2017 | https://conductscience.org/library/papers/29955492 | PubMed |
| 29030176 | Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex. | Eur J Pharm Sci | 2018 | https://conductscience.org/library/papers/29030176 | PubMed |
| 27428884 | Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach. | Clin Neuropharmacol | 2016 | https://conductscience.org/library/papers/27428884 | PubMed |
| 23103621 | The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation. | Acta Pharmacol Sin | 2012 | https://conductscience.org/library/papers/23103621 | PubMed |
| 21062333 | Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy. | J Clin Pharm Ther | 2011 | https://conductscience.org/library/papers/21062333 | PubMed |
| 18773196 | Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model. | Naunyn Schmiedebergs Arch Pharmacol | 2009 | https://conductscience.org/library/papers/18773196 | PubMed |
| 16978035 | Management of focal-onset seizures: an update on drug treatment. | Drugs | 2006 | https://conductscience.org/library/papers/16978035 | PubMed |
| 16896786 | Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics. | Eur J Clin Pharmacol | 2006 | https://conductscience.org/library/papers/16896786 | PubMed |
| 12847559 | Valproate: past, present, and future. | CNS Drug Rev | 2003 | https://conductscience.org/library/papers/12847559 | PubMed |
| 12269862 | Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. | CNS Drugs | 2002 | https://conductscience.org/library/papers/12269862 | PubMed |
| 9571300 | Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes? | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9571300 | PubMed |
| 7917080 | Newer antiepileptic drugs. Towards an improved risk-benefit ratio. | Drug Saf | 1994 | https://conductscience.org/library/papers/7917080 | PubMed |
| 7528126 | Evaluation of antiepileptic drug efficacy. A review of clinical trial design. | Drugs | 1994 | https://conductscience.org/library/papers/7528126 | PubMed |
| 7272157 | Methods of assessment of antiepileptic drugs. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7272157 | PubMed |
| 6990880 | Drug level monitoring in paediatric practice. | Arch Dis Child | 1980 | https://conductscience.org/library/papers/6990880 | PubMed |
| 6812608 | Intra-dose variation in plasma protein binding of sodium valproate in epileptic patients. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6812608 | PubMed |
| 6786896 | Valproic acid disposition in epileptic patients during combined antiepileptic maintenance therapy. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6786896 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/376307
GET https://conductscience.org/api/papers/v1/376307/cited_by?page=2